Drug related involvement of specific sites in fixed eruptions: A statistical evaluation

Journal of Dermatology

Volumn 23, Issue 8, 1996, Pages 530-534

  Sharma, Vinod K ^a   Dhar, Sandipan ^a   Gill, Amar Nath ^b  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

analgin; cotrimoxazole; fixed drug eruption; phenytoin; specific site; tetracycline

Indexed keywords

CIPROFLOXACIN; COTRIMOXAZOLE; DIPYRONE; METRONIDAZOLE; PHENYTOIN; PYRAZOLONE DERIVATIVE; TETRACYCLINE;

ARTICLE; DRUG ERUPTION; HUMAN; SKIN DEFECT; STATISTICS;

EID: 0029778431     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.1996.tb02646.x     Document Type: Article

References (22)

1. Korkij W, Soltani K: Fixed drug eruption: A brief review, Arch Dermatol, 120: 520-523, 1984.
2. Kauppinen K, Stupp S: Fixed eruptions: Causative drugs and challenge tests, Br J Dermatol, 112: 575-578, 1985.
3. Sehgal VN, Gangwani OP: An unusual symmetrical fixed drug eruption, Ind J Dermatol Venereol Leprol, 5: 172-173, 1985.
4. Parish LC, Witkowski JA: Pulsating fixed drug eruption due to tetracycline, Acta Derm Venereol (Stockh), 58: 545-547, 1978.
5. Guin JD, Haynie LS, Jackson D, Baker GF: Wandering fixed drug eruption. A mucocutaneous reaction to acetaminophen, J Am Acad Dermatol, 17: 394-402, 1987.
6. Shelly WB, Shelly ED: Nonpigmenting fixed drug reaction pattern: Examples caused by sensitivity to pseudoephedrine hydrochloride and tetrahydrozoline, J Am Acad Dermatol, 17: 403-407, 1987.
7. Valsecchi R, Cainelli T: Nonpigmenting fixed drug reaction to piroxicam, J Am Acad Dermatol, 21: 1300, 1989.
8. Brown SG: Fixed eruptions in deeply pigmented subjects: Clinical observations on 350 patients, Br Med J, 2: 1041-1044, 1964.
9. Csonka GW, Rosedale N, Walkden L: Balanitis due to fixed drug eruption associated with tetracycline therapy, Br J Vener Dis, 47: 42-44, 1971.
10. Talbot MD: Fixed genital drug eruption, Practitioner, 224: 823-824, 1980.
11. Derbes VJ: The fixed eruption, JAMA, 190: 765-766, 1964.
12. Fiumara NJ, Yakub M: Pigmented penile lesions associated with tetracycline therapy for sexually transmitted diseases, Sex Trans Dis, 8: 23-25, 1981.
13. Miller RG: Simultaneous Statistical Inference, 2nd ed, Springer-Verlag, New York, 1981, pp 215-219.
14. Sacerdoti G, Vozza A, Ruocco V: Identifying skin reactions to drugs, Int J Dermatol, 32: 469-479, 1973.
15. Thankappan TP, Zachariah J: Drug-specific clinical pattern in fixed drug eruptions, Int J Dermatol, 30: 867-870, 1991.
16. Choudhury SD: Fixed drug eruptions, Ind J Dermatol Venereol and Leprol, 21: 67-69, 1976.
17. Kanwar AJ, Bharija SC, Belhaj MS: Fixed drug eruptions in children: A series of 23 cases with provocation tests, Dermatologica, 172: 315-318, 1986.
18. Arndt KA, Jick H: Rates of reaction to drugs: A report from Boston Collaborative Drug Surveillance Program, JAMA, 235: 918-923, 1976.
19. Pellicano R, Civarella G, Lomuto M, Du-Giorgio G: Genetic susceptibility to fixed drug eruption. Evidence of link with HLA-B22, J Am Acad Dermatol, 30: 52-54, 1994.
20. Delany TJ: Tetracycline induced fixed drug eruption, Br J Dermatol, 83: 357-358, 1970.
21. Sukla SR: Drugs causing fixed drug eruptions, Dermatologica, 163: 160-163, 1981.
22. Pasricha JS: Drugs causing fixed eruptions, Br J Dermatol, 100: 183-185, 1979.